TickerFactsScreenerDevelopers

Voyager Therapeutics, Inc. (VYGR) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2015: $41.30M2016: -$42.48M2017: -$61.35M2018: -$15.89M2019: $48.67M2020: -$96.72M2021: -$53.52M2022: -$12.51M2023: $77.92M2024: -$15.31M2025: -$132.47M-$132.47M
2015Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$132.47M-765.2%
2024-$15.31M-119.6%
2023$77.92M+722.9%
2022-$12.51M+76.6%
2021-$53.52M+44.7%
2020-$96.72M-298.7%
2019$48.67M+406.3%
2018-$15.89M+74.1%
2017-$61.35M-44.4%
2016-$42.48M-202.9%
2015$41.30M—